industry
Artificial Intelligence (AI) · B2B · Bioinformatics · Biotechnology · Cloud Infrastructure · Pharmaceutical · SaaS · Simulation · Software
Size
1 - 10 employees
Stage
Other
founded in
2023
Examol is developing a software platform for computational drug discovery in the small molecule space. Their solution consists of a molecule database ready for AI-scale data ingress and egress, with a modern UI and API. Combined with powerful plug-ins and workflow orchestration, they offer barrier-free access to standard methodologies in computational chemistry, novel AI, and physics methods, easy to run at scale in the Cloud or customers’ premises. They aim to centralize data from computational chemistry calculations, automate and streamline intricate workflows to enhance productivity, access to innovation, and data reliability for drug discovery companies.
Something looks off?